Victory Capital Management Inc Catalyst Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 291,505 shares of CPRX stock, worth $6.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

291,505

Previous 275,509 5.81%

Holding current value

$6.22 Million

Previous $4.27 Million 35.81%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$15.19 - $21.35 $242,979 - $341,514	15,996 Added 5.81%	291,505 $5.8 Million
Q2 2024 Aug 05, 2024	SELL	$14.68 - $16.92 $48,165 - $55,514	-3,281 Reduced 1.18%	275,509 $4.27 Million
Q1 2024 May 03, 2024	BUY	$13.18 - $17.11 $277,663 - $360,456	21,067 Added 8.17%	278,790 $4.44 Million
Q4 2023 Feb 05, 2024	SELL	$11.78 - $17.29 $631,784 - $927,297	-53,632 Reduced 17.23%	257,723 $4.33 Million
Q3 2023 Nov 06, 2023	BUY	$11.69 - $15.02 $206,877 - $265,808	17,697 Added 6.03%	311,355 $3.64 Million
Q2 2023 Jul 27, 2023	BUY	$11.5 - $18.08 $54,153 - $85,138	4,709 Added 1.63%	293,658 $3.95 Million
Q1 2023 May 02, 2023	SELL	$14.34 - $21.05 $57,030 - $83,715	-3,977 Reduced 1.36%	288,949 $4.79 Million
Q4 2022 Feb 10, 2023	BUY	$12.25 - $19.5 $93,406 - $148,687	7,625 Added 2.67%	292,926 $5.45 Million
Q4 2022 Feb 09, 2023	SELL	$12.25 - $19.5 $988,464 - $1.57 Million	-80,691 Reduced 22.05%	285,301 $5.31 Million
Q3 2022 Nov 02, 2022	BUY	$7.06 - $15.52 $4,730 - $10,398	670 Added 0.18%	365,992 $4.7 Million
Q2 2022 Aug 01, 2022	SELL	$6.23 - $8.57 $92,727 - $127,555	-14,884 Reduced 3.91%	365,322 $2.56 Million
Q1 2022 May 04, 2022	BUY	$5.31 - $8.31 $1.44 Million - $2.25 Million	271,172 Added 248.7%	380,206 $3.04 Million
Q4 2021 Feb 07, 2022	SELL	$5.21 - $7.45 $194,317 - $277,862	-37,297 Reduced 25.49%	109,034 $739,000
Q3 2021 Nov 02, 2021	SELL	$4.85 - $6.04 $224,307 - $279,343	-46,249 Reduced 24.02%	146,331 $775,000
Q2 2021 Aug 03, 2021	SELL	$4.29 - $6.05 $42,428 - $59,834	-9,890 Reduced 4.88%	192,580 $1.11 Million
Q1 2021 May 04, 2021	BUY	$3.45 - $4.69 $205,657 - $279,575	59,611 Added 41.73%	202,470 $933,000
Q4 2020 Feb 01, 2021	BUY	$2.97 - $3.83 $91,508 - $118,006	30,811 Added 27.5%	142,859 $477,000
Q3 2020 Nov 09, 2020	BUY	$2.97 - $5.08 $70,133 - $119,959	23,614 Added 26.7%	112,048 $333,000
Q2 2020 Aug 07, 2020	BUY	$3.48 - $5.05 $26,879 - $39,006	7,724 Added 9.57%	88,434 $409,000
Q1 2020 May 04, 2020	BUY	$2.61 - $5.21 $36,740 - $73,341	14,077 Added 21.13%	80,710 $311,000
Q4 2019 Feb 06, 2020	BUY	$3.67 - $5.7 $4,345 - $6,748	1,184 Added 1.81%	66,633 $250,000
Q4 2019 Feb 04, 2020	BUY	$3.67 - $5.7 $83,474 - $129,646	22,745 Added 53.26%	65,449 $269,000
Q3 2019 Nov 12, 2019	BUY	$3.89 - $7.43 $166,118 - $317,290	42,704 New	42,704 $227,000

Others Institutions Holding CPRX

# of Institutions

327

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.2B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Catalyst Pharmaceuticals, Inc. Transaction History